Catheter Precision, Inc. (VTAK)
NYSEAMERICAN: VTAK · IEX Real-Time Price · USD
2.700
-0.100 (-3.57%)
At close: Jul 19, 2024, 4:00 PM
2.780
+0.080 (2.96%)
After-hours: Jul 20, 2024, 12:58 PM EDT

Catheter Precision Revenue

Catheter Precision had revenue of $439.00K in the twelve months ending March 31, 2024, with 387.78% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $82.00K. In the year 2023, Catheter Precision had annual revenue of $442.00K with 3,057.14% growth.

Revenue (ttm)
$439.00K
Revenue Growth
+387.78%
P/S Ratio
5.54
Revenue / Employee
$31,357
Employees
14
Market Cap
2.43M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023442.00K428.00K3,057.14%
Dec 31, 202214.00K-8.00K-36.36%
Dec 31, 202122.00K-237.00K-91.51%
Dec 31, 2020259.00K-6.94M-96.40%
Dec 31, 20197.20M942.00K15.06%
Dec 31, 20186.26M387.00K6.59%
Dec 31, 20175.87M-106.00K-1.77%
Dec 31, 20165.98M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
cbdMD 21.58M
InMed Pharmaceuticals 5.63M
Tenon Medical 3.21M
Helius Medical Technologies 668.00K
Aclarion 60.05K
Heart Test Laboratories 18.60K
Revenue Rankings